| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.0B | $5.8B | $1.4B | $5.2B | $5.1B | $1.2B | $1.1B | $1.1B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | $1.3B | $1.0B | $0.9B | $0.9B | $0.9B | $0.9B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | $1.3B | $1.0B | $0.9B | $0.9B | $0.9B | $0.9B |
| Net Income | $1.2B | $1.1B | $0.3B | $0.7B | $0.7B | $0.2B | $0.2B | $0.2B |
| EPS (Basic) | $14.27 | $11.99 | $2.92 | $7.55 | $7.30 | $1.96 | $1.73 | $1.48 |
| EPS (Diluted) | $14.07 | $11.94 | $2.88 | $7.47 | $7.22 | $1.93 | $1.69 | $1.45 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $30.8B | $29.1B | $28.1B | $25.5B | $29.8B | $29.0B | $26.0B | $23.1B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.1B | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Total Liabilities | $24.8B | $23.8B | $23.6B | $20.6B | $21.1B | $20.3B | $18.7B | $17.7B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $6.0B | $5.3B | $4.5B | $4.9B | $8.6B | $8.8B | $7.3B | $5.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.4B | $1.4B | $1.5B | $1.4B | $1.4B | $1.5B | $1.4B | $1.3B |
| Investing Cash Flow | $-0.6B | $-0.6B | $-0.9B | $-0.9B | $-0.9B | $-1.2B | $-0.8B | $-0.9B |
| Capital Expenditures | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-0.8B | $-0.7B | $-0.5B | $-0.5B | $-0.5B | $-0.3B | $-0.6B | $-0.4B |